Insider Trading & Ownership - IPI Legacy Liquidation Co (IMPLQ)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for IPI Legacy Liquidation Co
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-12-15
Sale
2023-12-19
6:00 pm
IMPEL PHARMACEUTICALS INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
575,000$0.12892$74,131280,294
(Indirect)
View
2021-11-19
Purchase
2021-11-22
5:05 pm
IMPEL NEUROPHARMA INCIMPLNELSON TIMOTHY S
Director
10,000$10.76$107,55410,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-04-05
Other
2024-04-09
4:20 pm
N/A
2029-11-20
IPI Legacy Liquidation CoIMPLQWilfong Diane E.
Director
68,867$00
(Direct)
View
2024-04-05
Other
2024-04-09
4:19 pm
N/A
2027-02-13
IPI Legacy Liquidation CoIMPLQNELSON TIMOTHY S
Director
85,192$010,000
(Direct)
View
2024-04-05
Other
2024-04-09
4:17 pm
N/A
2031-07-10
IPI Legacy Liquidation CoIMPLQAllison David D.
Director
37,511$00
(Direct)
View
2023-11-30
Other
2023-12-04
9:00 pm
N/A
N/A
IMPEL PHARMACEUTICALS INCIMPLBROOKFIELD Corp
BAM Partners Trust
Brookfield Asset Management ULC
10% Owner
445,294$03,117,057
(Indirect)
View
2023-11-30
Other
2023-12-04
9:00 pm
N/A
N/A
IMPEL PHARMACEUTICALS INCIMPLOaktree GCP Fund Delaware Holdings L.P.
Oaktree Diversified Income Fund Inc.
Oaktree AZ Strategic Lending Fund L.P.
Oaktree Loan Acquisition Fund L.P.
Oaktree LSL Fund Holdings EURRC S.a.r.l.
Oaktree LSL Fund Delaware Holdings EURRC L.P.
Oaktree PRE Life Sciences Fund L.P.
Oaktree Capital Group LLC
Atlas OCM Holdings LLC
10% Owner
445,294$03,117,057
(Indirect)
View
2023-11-30
Other
2023-12-04
9:00 pm
N/A
N/A
IMPEL PHARMACEUTICALS INCIMPLOaktree-TCDRS Strategic Credit LLC
Oaktree-Forrest Multi-Strategy LLC
Oaktree-TBMR Strategic Credit Fund C LLC
Oaktree-TBMR Strategic Credit Fund F LLC
Oaktree-TBMR Strategic Credit Fund G LLC
Oaktree-TSE 16 Strategic Credit LLC
INPRS Strategic Credit Holdings LLC
Oaktree Gilead Investment Fund AIF (Delaware) L.P.
Oaktree Specialty Lending Corp
Oaktree Strategic Credit Fund
10% Owner
445,294$03,117,057
(Indirect)
View

Ownership
2023-11-20
9:16 pm
N/A
N/A
IMPEL PHARMACEUTICALS INCIMPLBROOKFIELD Corp
BAM Partners Trust
Brookfield Asset Management ULC
10% Owner
0$02,671,763
(Indirect)
View

Ownership
2023-11-20
9:12 pm
N/A
N/A
IMPEL PHARMACEUTICALS INCIMPLOaktree GCP Fund Delaware Holdings L.P.
Oaktree Diversified Income Fund Inc.
Oaktree AZ Strategic Lending Fund L.P.
Oaktree Loan Acquisition Fund L.P.
Oaktree LSL Fund Holdings EURRC S.a.r.l.
Oaktree LSL Fund Delaware Holdings EURRC L.P.
Oaktree PRE Life Sciences Fund L.P.
Oaktree Capital Group LLC
Atlas OCM Holdings LLC
10% Owner
0$02,671,763
(Indirect)
View

Ownership
2023-11-20
9:09 pm
N/A
N/A
IMPEL PHARMACEUTICALS INCIMPLOaktree-TCDRS Strategic Credit LLC
Oaktree-Forrest Multi-Strategy LLC
Oaktree-TBMR Strategic Credit Fund C LLC
Oaktree-TBMR Strategic Credit Fund F LLC
Oaktree-TBMR Strategic Credit Fund G LLC
Oaktree-TSE 16 Strategic Credit LLC
INPRS Strategic Credit Holdings LLC
Oaktree Gilead Investment Fund AIF (Delaware) L.P.
Oaktree Specialty Lending Corp
Oaktree Strategic Credit Fund
10% Owner
0$02,671,763
(Indirect)
View
2023-06-16
Option Award
2023-06-20
6:41 pm
N/A
2033-06-15
IMPEL PHARMACEUTICALS INCIMPLCline Darren S
Director
13,222$013,222
(Direct)
View
2023-06-16
Option Award
2023-06-20
6:39 pm
N/A
2033-06-15
IMPEL PHARMACEUTICALS INCIMPLWilfong Diane E.
Director
13,222$013,222
(Direct)
View
2023-06-16
Option Award
2023-06-20
6:38 pm
N/A
2033-06-15
IMPEL PHARMACEUTICALS INCIMPLSHAH MAHENDRA
Director
13,222$013,222
(Direct)
View
2023-06-16
Option Award
2023-06-20
6:37 pm
N/A
2033-06-15
IMPEL PHARMACEUTICALS INCIMPLNELSON TIMOTHY S
Director
13,222$013,222
(Direct)
View
2023-06-16
Option Award
2023-06-20
6:36 pm
N/A
2033-06-15
IMPEL PHARMACEUTICALS INCIMPLAllison David D.
Director
13,222$013,222
(Direct)
View
2023-05-10
Option Award
2023-05-12
4:41 pm
N/A
2033-05-10
IMPEL PHARMACEUTICALS INCIMPLKalb Michael Wayne
CFO
222,500$0222,500
(Direct)
View

Ownership
2023-05-12
4:22 pm
N/A
N/A
IMPEL PHARMACEUTICALS INCIMPLKalb Michael Wayne
CFO
0$00
(Direct)
View
2023-04-12
Option Award
2023-04-14
4:58 pm
N/A
2033-04-11
IMPEL PHARMACEUTICALS INCIMPLCline Darren S
Director
20,013$020,013
(Direct)
View

Ownership
2023-04-13
6:10 pm
N/A
N/A
IMPEL PHARMACEUTICALS INCIMPLCline Darren S
Director
0$00
(Direct)
View

Ownership
2023-03-10
4:33 pm
N/A
N/A
IMPEL PHARMACEUTICALS INCIMPLAmin Rajiv
VP, Controller & Interim CFO
0$045,000
(Direct)
View
2023-02-14
Option Award
2023-02-16
6:23 pm
N/A
2033-02-13
IMPEL PHARMACEUTICALS INCIMPLPaolillo Leonard
Chief Commercial Officer
50,000$050,000
(Direct)
View
2023-02-14
Option Award
2023-02-16
6:22 pm
N/A
2033-02-13
IMPEL PHARMACEUTICALS INCIMPLHoekman John
Chief Scientific Officer
42,500$042,500
(Direct)
View
2023-02-14
Option Award
2023-02-16
6:20 pm
N/A
2033-02-13
IMPEL PHARMACEUTICALS INCIMPLLeaman John Harold
Chief Fin. & Business Officer
70,000$070,000
(Direct)
View
2023-02-14
Option Award
2023-02-16
6:19 pm
N/A
2033-02-13
IMPEL PHARMACEUTICALS INCIMPLADAMS ADRIAN
COB, CEO and President
200,000$0200,000
(Direct)
View
2022-12-31
Exercise
2023-01-04
6:46 pm
N/A
N/A
IMPEL PHARMACEUTICALS INCIMPLLeaman John Harold
Chief Fin. & Business Officer
10,571$06,944
(Direct)
View
2022-12-31
Tax Withholding
2023-01-04
6:46 pm
N/A
N/A
IMPEL PHARMACEUTICALS INCIMPLLeaman John Harold
Chief Fin. & Business Officer
3,627$3.756,944
(Direct)
View
2022-06-16
Option Award
2022-06-17
5:06 pm
N/A
2032-06-15
IMPEL PHARMACEUTICALS INCIMPLWilfong Diane E.
Director
12,789$012,789
(Direct)
View
2022-06-16
Option Award
2022-06-17
5:05 pm
N/A
2032-06-15
IMPEL PHARMACEUTICALS INCIMPLSHAH MAHENDRA
Director
12,789$012,789
(Direct)
View
2022-06-16
Option Award
2022-06-17
5:03 pm
N/A
2032-06-15
IMPEL PHARMACEUTICALS INCIMPLNELSON TIMOTHY S
Director
12,789$012,789
(Direct)
View
2022-06-16
Option Award
2022-06-17
5:02 pm
N/A
2032-06-15
IMPEL PHARMACEUTICALS INCIMPLPARKER H STEWART
Director
12,789$012,789
(Direct)
View
2022-06-16
Option Award
2022-06-17
5:00 pm
N/A
2032-06-15
IMPEL PHARMACEUTICALS INCIMPLAllison David D.
Director
12,789$012,789
(Direct)
View
2022-03-29
Exercise
2022-03-30
9:54 pm
N/A
2027-02-13
IMPEL NEUROPHARMA INCIMPLSHREWSBURY STEPHEN B
Chief Medical Officer
24,606$097,990
(Direct)
View
2022-03-29
Exercise
2022-03-30
9:54 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLSHREWSBURY STEPHEN B
Chief Medical Officer
24,606$1.9797,990
(Direct)
View
2022-01-26
Option Award
2022-01-28
5:06 pm
N/A
2032-01-25
IMPEL NEUROPHARMA INCIMPLSHREWSBURY STEPHEN B
Chief Medical Officer
30,000$030,000
(Direct)
View
2022-01-26
Option Award
2022-01-28
5:05 pm
N/A
2032-01-25
IMPEL NEUROPHARMA INCIMPLPaolillo Leonard
Chief Commercial Officer
40,000$040,000
(Direct)
View
2022-01-26
Option Award
2022-01-28
5:04 pm
N/A
2032-01-25
IMPEL NEUROPHARMA INCIMPLLeaman John Harold
Chief Fin. & Business Officer
100,000$0100,000
(Direct)
View
2022-01-26
Option Award
2022-01-28
5:03 pm
N/A
2032-01-25
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
35,000$035,000
(Direct)
View
2022-01-26
Option Award
2022-01-28
5:01 pm
N/A
2032-01-25
IMPEL NEUROPHARMA INCIMPLADAMS ADRIAN
COB, CEO and President
175,000$0175,000
(Direct)
View
2021-12-22
Exercise
2021-12-23
4:50 pm
N/A
2021-12-22
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
20,000$0128,221
(Direct)
View
2021-12-22
Exercise
2021-12-23
4:50 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
20,000$1.64128,221
(Direct)
View
2021-10-19
Option Award
2021-10-21
5:31 pm
N/A
2031-10-19
IMPEL NEUROPHARMA INCIMPLLeaman John Harold
Chief Fin. & Business Officer
10,571$010,571
(Direct)
View
Goto 0, 1, 2, Next